uniQure (QURE) Non-Current Deferred Tax Liability (2021 - 2026)

uniQure's (QURE) quarterly Non-Current Deferred Tax Liability came in at $7.8 million in Q1 2026, up 6.24% year-on-year from $7.3 million in Q1 2025, and down 2.15% quarter-over-quarter from $8.0 million in Q4 2025.

uniQure (QURE) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends

uniQure's Non-Current Deferred Tax Liability history runs 6 years deep, the most recent figure standing at $7.8 million for Q1 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability rose 6.24% year-over-year to $7.8 million in Q1 2026; TTM through Mar 2026 was $7.8 million, a 6.24% increase from a year earlier, with the FY2025 full-year figure at $8.0 million, up 13.12% from the prior year.
  • Non-Current Deferred Tax Liability fell to $7.8 million in Q1 2026 per QURE's latest filing, from $8.0 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $11.3 million in Q1 2022 and bottomed at $4.9 million in Q3 2023.
  • The 5-year median for Non-Current Deferred Tax Liability is $7.6 million (2024), against an average of $7.8 million.
  • Across the five-year window, Non-Current Deferred Tax Liability slumped 42.77% in 2023 and soared 55.11% in 2024, its largest moves.
  • Year by year, Non-Current Deferred Tax Liability stood at $8.3 million in 2022, then slipped by 8.65% to $7.5 million in 2023, then decreased by 6.63% to $7.0 million in 2024, then climbed by 13.12% to $8.0 million in 2025, then decreased by 2.15% to $7.8 million in 2026.
  • Per Business Quant, the three latest QURE Non-Current Deferred Tax Liability figures stand at $7.8 million (Q1 2026), $8.0 million (Q4 2025), and $8.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 uniQure 2.47 Bn 2.47 Bn 3.34 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.80 Mn
Mar 31, 2026 7.80 Mn
Dec 31, 2025 7.97 Mn
Dec 31, 2025 7.97 Mn
Sep 30, 2025 7.96 Mn
Sep 30, 2025 7.96 Mn
Jun 30, 2025 7.96 Mn
Jun 30, 2025 7.96 Mn
Mar 31, 2025 7.34 Mn
Mar 31, 2025 7.34 Mn
Dec 31, 2024 7.04 Mn
Dec 31, 2024 7.04 Mn
Sep 30, 2024 7.63 Mn
Sep 30, 2024 7.63 Mn
Jun 30, 2024 7.32 Mn
Jun 30, 2024 7.32 Mn
Mar 31, 2024 7.38 Mn
Mar 31, 2024 7.38 Mn
Dec 31, 2023 7.54 Mn
Dec 31, 2023 7.54 Mn